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Abstract
Background: Antibacterial peptides are important components of the innate immune system,
used by the host to protect itself from different types of pathogenic bacteria. Over the last few
decades, the search for new drugs and drug targets has prompted an interest in these antibacterial
peptides. We analyzed 486 antibacterial peptides, obtained from antimicrobial peptide database
APD, in order to understand the preference of amino acid residues at specific positions in these
peptides.
Results: It was observed that certain types of residues are preferred over others in antibacterial
peptides, particularly at the N and C terminus. These observations encouraged us to develop a
method for predicting antibacterial peptides in proteins from their amino acid sequence. First, the
N-terminal residues were used for predicting antibacterial peptides using Artificial Neural Network
(ANN), Quantitative Matrices (QM) and Support Vector Machine (SVM), which resulted in an
accuracy of 83.63%, 84.78% and 87.85%, respectively. Then, the C-terminal residues were used for
developing prediction methods, which resulted in an accuracy of 77.34%, 82.03% and 85.16% using
ANN, QM and SVM, respectively. Finally, ANN, QM and SVM models were developed using N and
C terminal residues, which achieved an accuracy of 88.17%, 90.37% and 92.11%, respectively. All
the models developed in this study were evaluated using five-fold cross validation technique. These
models were also tested on an independent or blind dataset.
Conclusion: Among antibacterial peptides, there is preference for certain residues at N and C
termini, which helps to demarcate them from non-antibacterial peptides. Both the termini play a
crucial role in imparting the antibacterial property to these peptides. Among the methods
developed, SVM shows the best performance in predicting antibacterial peptides followed by QM
and ANN, in that order. AntiBP (Antibacterial peptides) will help in discovering efficacious
antibacterial peptides, which we hope will prove to be a boon to combat the dreadful antibiotic
resistant bacteria. A user friendly web server has also been developed to help the biological
community, which is accessible at http://www.imtech.res.in/raghava/antibp/.
Background
In the past few decades, a large number of bacterial strains
have evolved ways to adapt or become resistant to the cur-
rently available antibiotics [1]. Researchers are focusing
on alternative drugs based on antimicrobial peptides,
which play an important role in innate immunity. As part
of innate immune system, antimicrobial peptides provide
protection against a wide variety of microorganisms in
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are very diverse with respect to amino acid sequence and
secondary structure but share certain properties, such as
affinity for the negatively charged phospholipids that are
present on the outer surfaces of the cytoplasmic mem-
brane of many microbial species. These peptides are ubiq-
uitous, simple and effective factors acting within the
innate immune system. Their short length and fast & effi-
cient action against microbes has made them potential
candidates as peptide drugs [4,11]. Several peptides and
their derivatives have already passed clinical trials success-
fully [12,13] and several others are considered as potential
therapeutics [12].
Antimicrobial peptides have a broad spectrum of activity,
including activity against bacteria, fungi, viruses, and even
cancer cells [14]. Other than having pathogen-lytic activi-
ties, these peptides have other properties like anti-tumour
activity; mitogen activity, or act as signalling molecules
[14]. In addition, they have a number of biotechnological
applications, e.g. in transgenic plants [15,16], in aquacul-
ture, and as aerosol spray for patients of cystic fibrosis
[17]. In the past extensive work has been done in the field
of antibacterial peptides, describing their identification,
characterization, mechanism of action etc. The informa-
tion about these peptides has been collected and com-
piled; following are major databases on antimicrobial
peptides I) ANTIMIC have around 1700 sequences [18] ii)
AMSDb consists 804 antimicrobial peptides of eukaryotic
origin [19], iii) Peptaibol consists of around 300 antibi-
otic peptides originated from fungal organisms [20] and
iv) APD consists of detailed information for 525 antimi-
crobial peptides [21].
Recently, a HMM (Hidden Markov Model) based method
has been developed for searching conserved motifs of β-
defensin family in genome databases [22]. The antibacte-
rial peptides have little sequence homology, despite com-
mon properties [12]. Thus it is difficult to develop method
for predicting the antibacterial peptides based on similar-
ity. Moreover, experimental methods for identification
and designing of antibacterial peptides are costly, time
consuming and resource intensive. Thus there is a need to
develop computational tools for predicting antibacterial
peptides, which could be used to design potent peptides
against bacterial pathogens.
In the present study, a systematic attempt has been made
to understand this important class of peptides and to
develop an algorithm for predicting antibacterial peptides
with high accuracy. First, we collected and analyzed anti-
bacterial peptides in order to understand preference of
residue type at different positions. We also compared
composition of antibacterial and non-antibacterial pep-
tides. We analyzed residues of both N and C termini as
both play important role in their activity; for example, C-
terminus is responsible for the membrane interaction and
pore formation, while the N-terminal region is important
in bacteria-specific interaction process [23]. Based on our
observation, we developed our methods using both N-ter-
minus and C-terminus approach. In this study, three pop-
ular classification techniques, namely, Quantitative
Matrix (QM), Artificial Neural Network (ANN) and Sup-
port Vector Machine (SVM), have been used to predict
antibacterial peptides.
Results
Analysis of the antibacterial peptides
The frequency of occurrence of all 20 natural amino acids
at both termini was examined. It was observed that partic-
ular types of residues are preferred over others in anti-bac-
terial peptides. In order to demonstrate residue preference
at different position of antibacterial peptides, sequence
logos using plogo program [24] were generated. The
sequence logos of 15 N-terminal and C-terminal residues
are shown in Figure 1 and 2, respectively. As shown in Fig-
ure 1, certain residues are more abundant at specific posi-
tions, e.g., G, F, V, R at first position; L, I, W, F at 2nd
position etc. Overall antibacterial peptides are dominated
by certain type of residues like G, R, K, L etc., being present
at most of the positions. Similarly, certain residues are
preferred at the C-terminus, for example residues K, G, C,
and R are preferred at most of the positions.
In order to understand biasness of residues in antibacte-
rial peptides, we computed frequency of each type of the
residues in antibacterial and non-antibacterial peptides.
As shown in Figure Additional file: 1 (Supplementary
Material), residues G and F are significantly higher at first
position of N-terminus of antibacterial peptides than that
of non-antibacterial peptides. Similarly residues W, I, L, F
are more frequent at the 2nd position of N-terminus of
Sequence logo of first fifteen residues (N-terminus) of anti-bacterial peptidesFig re 1
The figure depicts the sequence logo of first fifteen residues 
(N-terminus) of antibacterial peptides, where size of residue 
is proportional to its propensityPage 2 of 10
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peptides. We also computed polar, non-polar, positive
charge residues etc. at different positions of antibacterial
peptides and compared with non-bacterial peptides (See
Figure S11 to S20). Though both termini possess higher
frequency of positively charged residues (K and R), the dif-
ference between the frequency of these residues between
the antibacterial and non-antibacterial peptides is higher
at the C-terminus. The difference in the frequencies of the
positively charged residues between the positive and neg-
ative examples increases from position 1 to 5 at the N-ter-
minus, whereas it tends to decrease from position 1 to 5
at the C-terminus. While higher frequency of the posi-
tively charged residues may be helping the C-terminus to
interact with the negatively charged bacterial membrane,
positively charged residues at the N-terminus may help in
the interaction between these peptides and intracellular
components like DNA and RNA, thus hampering the cru-
cial bacterial functions. The proportion of Cysteine is
higher at the N-terminus also. The proportion of nega-
tively charged amino acids (D and E) were also found to
be very low, as expected, since these may interfere during
the course of penetration of the negatively charged cell
membrane of the bacteria.
Overall compositional biasness
As shown in the above analysis (Figure S1-S20), antibac-
terial peptides have preference for certain types of residues
at certain positions. The next question is if the overall
composition of these antibacterial is also different from
that of non-antibacterial peptides. Thus we compared the
overall amino acid composition of antibacterial and non-
antibacterial peptides. As shown in Figure 3, certain resi-
dues like C, G, I and K are significantly higher in antibac-
terial peptides, as expected, since these residues are
preferred at certain positions in antibacterial peptides. It is
also noteworthy that residue R was not significantly
higher in antibacterial peptides, though it was preferred at
certain positions. Certain residues like D, E, S and P are
not preferred in antibacterial peptides.
Prediction of Antibacterial Peptides
Whole peptide
The prediction of antibacterial peptides is difficult, but
very important. In the past attempts have been made, but
these methods are subjective, based on physico-chemical
property plots, than quantitative. The prediction of anti-
bacterial peptides is difficult due to variation in the size of
antibacterial peptides, since the machine learning tech-
niques need fixed length pattern. Thus the question was
how to circumvent this problem and develop a machine
learning based method for predicting antibacterial pep-
tides. As shown in Figure 3, amino acid composition of
antibacterial peptides is significantly different from that of
non-antibacterial peptides. In the past, methods have
been developed based on machine learning techniques,
using protein composition to classify the proteins (in
spite of their variation in size), particularly for subcellular
localization of proteins. Thus, we have developed a SVM
based model using amino acid composition on our main
dataset and achieved an accuracy of 89.04% with sensitiv-
ity of 89.92% and specificity of 88.09% (Table 1). Though
we could predict antibacterial peptides with high accuracy
using amino acid composition, we realised the weakness
of this composition-based approach, since it is difficult to
decide what length we should search in proteins as length
of antibacterial peptides varied from 5 to ~80. Despite its
better performance, it is impossible to use this approach
for searching antibacterial peptides in genomes or pro-
teins.
Overall amino acid composition of antibacterial vs non-anti-bacterial peptidesFigure 3
Overall amino acid composition of antibacterial vs non-anti-
bacterial peptides. This figure represents a comparison of 
composition bias of various amino acids in antibacterial and 
non-antibacterial peptides.
Sequence logo of last fifteen residues (C-terminus) of anti-bacterial peptidesFig re 2
The figure depicts the sequence logo of last fifteen residues 
(C-terminus) of antibacterial peptides, where size of residue 
is proportional to its propensity.Page 3 of 10
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It has been observed that certain types of residues are pre-
ferred at the N-terminal regions of antibacterial peptides.
Thus we made an attempt to develop a method for pre-
dicting antibacterial peptides using their N-terminal resi-
dues. We created a dataset NT5 which consists of 5 N-
terminal residues of antibacterial and non-antibacterial
peptides (See Material and Methods). Then we developed
a SVM model using the amino acid composition of these
N-terminal residues and achieved an accuracy of 73.20%
with 73.65% sensitivity and 72.75% specificity (Table 1).
The performance of this SVM module is much lower than
of SVM module using composition of whole peptide, but
this module can be used to scan antibacterial peptides in
protein sequences. As we are using only first five residues
here, it's possible to use these residues as binary pattern
instead of composition. In binary pattern a vector of
dimension 20 represents a residue, and for 5 residues the
input vector of dimension is 100 (20 × 5). As shown in
Table 1, we achieved an accuracy of 74.55% using the
binary pattern based SVM model. Overall, the binary-
based SVM model performs better than composition
based model using first five N-terminal residues. Thus we
extended our binary-based SVM models for predicting
antibacterial peptides using more number of residues
from the N-terminus. As shown in Table 2, we achieved an
accuracy of 86.45% with specificity of 87.68% using
binary-based SVM using the first 10 N-terminal residues.
We got the best accuracy using first 15 N-terminal resi-
dues, which is 87.85% with specificity 87.98%.
C-terminal and N+C terminal
We have used the same strategy for the C-terminus as used
for the N-terminus. The performance of binary-based SVM
model using 15 C-terminal residues is shown in Table 3.
Though performance was lower using C-terminal resi-
dues, the trend of performance was same. In order to
check if using the N and C-termini of the peptides
together will enhance the accuracy of the method, we
developed a N+C-terminus based approach. In this
approach the first and last 15 residues of each peptide in
the original dataset were joined in order to create the pos-
itive dataset of NC-termini based method. Similar strategy
as used in the N and C termini approaches were applied
in this approach also. The performance of binary-based
SVM model using N+C terminal residues is shown in
Table 3. We got an accuracy of 92.11% with 92.11% spe-
cificity using binary-based SVM model using the first and
last 15 residues. This model performs better than other
models. The trend of performance in this case too follows
the trend shown by the above two approaches, but the
performance of this approach.
Quantitative Matrices (QM)
In case of QM, the contribution of each residue for each
position of antibacterial peptide has been calculated. A
matrix with weights for each amino acid residue in every
position of peptide was generated using Equation 1. Table
S1 in supplementary file shows the propensity of each res-
idue at each position in antibacterial peptides. Higher
positive score of a residue at a given position means this
Table 1: The performance of SVM models using amino acid compositions of whole peptides and five residues of N-terminus. Last 
column shows performance of binary-based SVM model using first five residues of peptides.
Whole Peptide Composition 5 N-terminal residue Composition 5 N-terminal binary Pattern
Threshold Sen. Spec. Acc. Sen. Spec. Acc. Sen. Spec. Acc.
-1 98.15 60.45 80.13 97.31 25.45 61.38 95.81 24.25 60.03
-0.9 97.94 63.60 81.53 95.21 30.54 62.87 94.31 30.54 62.43
-0.8 97.53 67.19 83.03 93.71 35.33 64.52 93.71 37.13 65.42
-0.7 97.12 70.56 84.43 91.62 39.82 65.72 91.62 43.11 67.37
-0.6 96.91 72.81 85.39 90.42 46.11 68.26 90.12 48.50 69.31
-0.5 96.30 76.18 86.68 89.22 50.60 69.91 86.83 54.19 70.51
-0.4 95.88 77.53 87.11 87.72 55.09 71.41 85.03 59.88 72.46
-0.3 94.65 80.90 88.08 84.73 58.98 71.86 82.34 64.97 73.65
-0.2 93.42 84.27 89.04 81.44 63.47 72.46 80.24 68.86 74.55
0 89.92 88.09 89.04 73.65 72.75 73.20 74.25 74.85 74.55
0.1 88.48 89.44 88.94 70.36 76.65 73.50 70.66 77.54 74.10
0.2 86.63 90.56 88.51 66.77 79.64 73.20 67.96 83.83 75.90
0.3 84.98 91.01 87.86 63.47 83.83 73.65 64.97 88.32 76.65
0.4 83.74 93.03 88.18 57.49 86.83 72.16 60.78 88.92 74.85
0.5 80.04 93.26 86.36 53.59 89.52 71.56 57.78 90.12 73.95
0.6 77.37 94.83 85.71 48.50 91.62 70.06 54.49 91.02 72.75
0.7 75.51 95.28 84.96 44.61 94.01 69.31 51.50 93.41 72.46
0.8 72.02 95.28 83.14 39.22 94.91 67.07 44.91 95.51 70.21
0.9 67.90 96.40 81.53 34.43 96.11 65.27 39.52 96.11 67.81
1 64.61 97.53 80.34 29.04 97.90 63.47 32.34 97.01 64.67Page 4 of 10
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W, D and C are highly preferred at positions 1, 2, 3, 4 and
5. Similarly, higher negative scores mean that residue is
not preferred in antibacterial peptides at that position.
One of the major advantages of QM is that the effect of
each residue on antibacterial activity of peptide could be
easily estimated. As shown in Table 4, we achieved an
accuracy of 84.78%, 82.03% and 90.37%, using 15 resi-
dues of N, C and N+C terminal of peptides, respectively.
Artificial Neural Network (ANN)
The neural network is a powerful machine learning tech-
nique commonly used in the field of bioinformatics. Thus
we also used this technique in this study for predicting
antibacterial peptides. The performance of ANN-based
method using 15 N-terminal residues is shown in Table 5.
We achieved an accuracy of 83.63%, 77.34% and 88.17%,
using 15 residues of N, C and N+C terminal of peptides,
respectively. Though the trend was same as that of SVM,
QM and ANN models, the performance of ANN was poor
compared to other techniques. This is probably due to the
small number of peptides used for training the models.
Consensus approach
In an attempt to enhance the prediction accuracy we tried
the consensus approach. In this approach SVM, QM and
ANN, were separately used to predict whether a peptide is
antibacterial or not. A peptide was considered to be pre-
dicted positive only if at least two of these techniques pre-
dict it as a positive. Otherwise the peptide was predicted
negative. The accuracy of this consensus prediction was
calculated. This was done for all the three approaches i.e.
N-terminal; C-terminal and NC-terminal approach (Table
6). It was observed that the performance of consensus
model was slightly better than that of SVM model.
Performance on independent or blind dataset
The models developed in this study were evaluated on an
independent dataset (Table 7). These antibacterial pep-
tides in the independent dataset were not used for devel-
oping above models either in training or testing. This
dataset consists of 39 antimicrobial peptides obtained
from Swiss-Prot. As shown in Table 7, SVM, ANN and QM
correctly predicted 23, 19 and 21 antibacterial peptides,
respectively, using N-terminal residues of peptides. In case
of C-terminus based approach SVM, ANN and QM cor-
rectly predicted 30, 27 and 29 peptides, respectively. It
was interesting to note that the C-terminus based models
perform better than the N-terminus based models, which
is in contrast to the results when evaluated using five-fold
cross validation. The models based on N+C termini cor-
rectly predicted 26, 25 and 27 peptides, using SVM, ANN
and QM, respectively. Overall performance of our models
was very poor on independent dataset in comparison to
performance on the main dataset. In order to understand
the reason of poor performance we randomly extracted 39
peptides from the main dataset to form a new independ-
ent dataset and added 39 peptides from the old independ-
ent dataset to the main dataset. Then we retrained our
models and evaluated their performance on 39 peptides
Table 2: The performance of binary-based SVM models using 10, 15 and 20 residues of N-terminus.
10 N-terminal residues 15 N-terminal residues 20 N-terminal residues
Threshold Sen. Spec. Acc. Sen. Spec. Acc. Sen. Spec. Acc.
-1 99.75 13.55 56.65 97.95 46.55 72.25 99.10 29.85 64.48
-0.9 99.75 17.98 58.87 96.93 51.15 74.04 98.81 34.93 66.87
-0.8 99.26 25.12 62.19 96.68 57.54 77.11 98.51 44.48 71.49
-0.7 98.77 34.48 66.63 96.16 60.36 78.26 97.91 49.85 73.88
-0.6 97.04 42.86 69.95 95.65 65.22 80.43 97.01 57.91 77.46
-0.5 95.81 50.99 73.40 95.40 68.29 81.84 96.12 63.58 79.85
-0.4 94.33 59.61 76.97 93.86 73.66 83.76 94.33 69.25 81.79
-0.3 91.87 67.73 79.80 92.33 76.98 84.65 91.64 75.52 83.58
-0.2 90.64 74.38 82.51 91.05 81.33 86.19 89.55 80.00 84.78
0 85.22 87.68 86.45 87.72 87.98 87.85 85.37 85.37 85.37
0.1 81.28 90.39 85.84 85.93 91.30 88.62 82.69 89.85 86.27
0.2 78.33 93.60 85.96 83.63 92.84 88.24 81.79 94.03 87.91
0.3 74.63 95.07 84.85 81.59 93.86 87.72 78.81 95.82 87.31
0.4 69.21 96.80 83.00 79.03 93.86 86.45 75.82 96.72 86.27
0.5 65.76 98.03 81.90 75.70 94.63 85.17 72.24 97.31 84.78
0.6 59.85 99.01 79.43 73.40 95.40 84.40 67.46 98.21 82.84
0.7 51.48 99.51 75.49 70.08 95.65 82.86 59.70 99.10 79.40
0.8 43.10 99.75 71.43 62.92 96.42 79.67 51.34 99.10 75.22
0.9 32.27 99.75 66.01 57.29 96.93 77.11 46.57 99.40 72.99
1 25.62 99.75 62.68 52.43 97.95 75.19 37.31 99.70 68.51Page 5 of 10
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formance of models on these 39 peptides was as good as
performance on main dataset. This shows that our 39
original peptides used as independent dataset have either
some uniqueness or some problem. Thus we reanalyzed
these peptides and observed that 24 out of 39 are pure
peptides (only antibacterial peptides) and 15 peptides are
precursors to antibacterial peptides (containing both the
signal sequence and the antibacterial peptide) that require
further processing in order to produce active antibacterial
peptides. The poor performance on independent dataset
may be due to inclusion of these precursor sequences in
the independent dataset as the dataset used for training
the method contains only active antibacterial peptides
(and not precursors of antibacterial peptides). Thus we
checked the performance of our method on these 24
active antibacterial sequences, and as expected the per-
formance of our method on these 24 sequences was as
good as on main dataset.
Discussion
In the past attempts have been made to develop methods
and strategies for designing effective antimicrobial pep-
tides [25,26]. In this paper we have made systematic and
comprehensive effort to understand and predict antibac-
terial peptides. As shown Figure 1 and 2, antibacterial pep-
tides have preference for certain types of residues at
certain positions. This observation is very important for
experimentalists in designing de-novo antibacterial pep-
tides; they may substitute amino acids at certain positions
in order to make the peptides more effective. The quanti-
tative matrices provide the magnitude of contribution of
each type of residue at each position of antibacterial pep-
tide. This information can be used directly for designing
antibacterial peptides (See Supplementary Material). The
major challenge was to develop an accurate method for
predicting antibacterial peptides due to two major rea-
sons; i) the antibacterial peptides have lot of variation in
size and machine learning software need fixed length pat-
tern and ii) experimentally proven non-antibacterial are
not available which are very important for developing the
method. This problem is similar to B-cell epitope predic-
tion [27]. In order to handle the problem we developed
methods using only limited number of residues from the
N and C termini of peptides. In order to generate non-
antibacterial peptides or negative examples, we obtained
peptides randomly from non-secretory proteins [28].
Though some these peptides can be antibacterial, but
chances are very rare.
First we attempted to develop models to discriminate
antibacterial peptides from non-antibacterial peptides
using whole peptides. In this case we used amino acid
composition of peptides as input for our models. Though
this model discriminates antibacterial peptides with high
accuracy, it is difficult to use this model for scanning
potential antibacterial proteins. Thus wee used N-termi-
nal, C-terminal and N+C terminal approaches, as both N
and C-termini play an important role in antibacterial
activity, as suggested by the literature cited. The C-termi-
Table 3: The performance of binary-based SVM models using 15 N, C and N+C terminal residues.
N-terminal C-terminal N+C terminal
Threshold Sen. Spec. Acc. Sen. Spec. Acc. Sen. Spec. Acc.
-1 97.95 46.55 72.25 99.74 13.80 56.77 99.07 37.59 68.33
-0.9 96.93 51.15 74.04 99.48 21.35 60.42 98.61 43.85 71.23
-0.8 96.68 57.54 77.11 99.48 28.65 64.06 98.38 51.74 75.06
-0.7 96.16 60.36 78.26 98.96 37.76 68.36 97.91 59.63 78.77
-0.6 95.65 65.22 80.43 97.66 43.75 70.70 97.45 65.89 81.67
-0.5 95.40 68.29 81.84 97.14 52.08 74.61 96.98 73.09 85.03
-0.4 93.86 73.66 83.76 95.57 59.38 77.47 96.52 78.89 87.70
-0.3 92.33 76.98 84.65 93.23 67.19 80.21 95.59 84.22 89.91
-0.2 91.05 81.33 86.19 90.36 73.44 81.90 94.43 87.47 90.95
0 87.72 87.98 87.85 84.38 85.94 85.16 92.11 92.11 92.11
0.1 85.93 91.30 88.62 82.03 88.28 85.16 91.18 94.66 92.92
0.2 83.63 92.84 88.24 78.91 93.49 86.20 89.33 96.06 92.69
0.3 81.59 93.86 87.72 76.04 94.79 85.42 85.85 96.29 91.07
0.4 79.03 93.86 86.45 71.61 96.61 84.11 83.99 97.45 90.72
0.5 75.70 94.63 85.17 65.36 97.66 81.51 81.67 98.14 89.91
0.6 73.40 95.40 84.40 60.68 98.96 79.82 78.19 98.61 88.40
0.7 70.08 95.65 82.86 55.21 98.96 77.08 73.78 99.54 86.66
0.8 62.92 96.42 79.67 46.09 98.96 72.53 68.21 99.54 83.87
0.9 57.29 96.93 77.11 34.38 99.74 67.06 61.02 99.77 80.39
1 52.43 97.95 75.19 24.22 100.00 62.11 51.28 99.77 75.52Page 6 of 10
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whereas the N-terminus helps in bacteria specific interac-
tion process. One of the limitations of Machine Learning
Techniques is that they require fixed length input vectors.
Antibacterial peptides, on the contrary, are of varying
length. Therefore, peptides of fixed lengths (5, 10, 15 20)
were used to develop a SVM model. The number of pep-
tides reduced significantly when 20 or 25 residue long
peptides are used instead of 15 residues (335 20 mer pep-
tides & 252 25 mer peptides). Thus in this study, we made
models using 15 residues only as most (~60%) of the anti-
bacterial peptides are 20–30 residues long. The perform-
ance of all the approaches was evaluated using five fold
cross validation techniques. Performance of all modules
based on QM, ANN and SVM was impressive but SVM
based module using fifteen residues was the best. The
poor performance of the ANN as compared to QM and
SVM is due to the over optimization of ANN. It has been
shown in the past that ANN suffers with the problem of
over optimization when the training dataset is small [29].
AntiBP, though has some limitations like not including
post-translational modifications and topological aspects,
but to the best of our knowledge it is first method devel-
oped for predicting and designing potential antibacterial
peptides. Our methods are likely to help the researchers in
finding and in designing better peptides-based antibiot-
ics.
Conclusion
Currently a great deal of interest is shown in antibacterial
peptides, so called "nature's antibiotics", which seem to
be promising to overcome the growing problem of antibi-
otic resistance [30-32]. The design of novel peptides with
antimicrobial activities requires the development of
methods for narrowing down the candidate peptides so as
to enable rational experimentation by wet-lab scientists.
AntiBP is one such method meant to discover efficacious
antibacterial peptides that we hope could prove to be a
boon to combat the dreadful antibiotic resistant bacteria.
Methods
Dataset
We extracted 486 antibacterial peptides having less than
61 residues from APD database [21]. We analyzed the
length of these peptides and observed that most of them
have more than 15 residues. Thus we created a dataset of
antibacterial peptides having number of residues between
15 and 60. After removing identical peptides, we got a
dataset of 436 non-redundant antibacterial peptides, also
called positive dataset. In order to generate negative data-
set or dataset of non-antibacterial peptides, we extracted
equal number of peptides randomly from non-secretary
proteins. Our final dataset, called main dataset, has 436
antibacterial and 436 random peptides.
N-terminal and C-terminal Dataset
In addition to the main dataset, we also created other
datasets (e.g. NT5, NT10, NT15, CT15, and NTCT15)
Table 4: The performance of QM models using 15 residues of N, C and N+C termini.
N-terminal C-terminal N+C terminal
Theshold Sen. Spec. Acc. Sen. Spec. Acc. Sen. Spec. Acc.
-1 90.28 68.54 79.41 91.41 57.29 74.35 91.18 88.63 89.91
-0.9 89.77 70.84 80.31 91.15 60.42 75.78 90.72 89.33 90.02
-0.8 89.77 73.66 81.71 90.62 62.50 76.56 90.49 89.79 90.14
-0.7 89.26 75.96 82.61 90.10 66.67 78.39 90.26 90.49 90.37
-0.6 87.98 77.49 82.74 88.54 68.75 78.65 90.02 90.72 90.37
-0.5 87.21 79.03 83.12 87.76 71.35 79.56 89.79 92.81 91.30
-0.4 86.19 80.82 83.50 87.50 73.70 80.60 89.10 93.04 91.07
-0.3 85.42 83.12 84.27 86.46 75.26 80.86 88.40 93.74 91.07
-0.2 84.65 84.91 84.78 84.90 77.08 80.99 88.17 94.66 91.42
0 82.10 87.72 84.91 81.25 82.81 82.03 87.01 96.29 91.65
0.1 80.82 89.00 84.91 79.69 83.59 81.64 86.77 96.52 91.65
0.2 79.54 90.03 84.78 77.60 85.94 81.77 86.08 96.75 91.42
0.3 78.26 91.05 84.65 76.04 86.98 81.51 85.38 96.75 91.07
0.4 76.98 92.33 84.65 73.44 88.54 80.99 84.69 96.98 90.84
0.5 74.94 92.33 83.63 71.09 89.58 80.34 83.06 96.98 90.02
0.6 73.15 92.58 82.86 67.71 90.89 79.30 82.37 97.91 90.14
0.7 71.10 93.86 82.48 66.93 92.45 79.69 81.44 98.14 89.79
0.8 69.82 94.12 81.97 65.89 92.97 79.43 81.21 98.38 89.79
0.9 69.05 95.40 82.23 63.80 93.75 78.78 80.51 98.38 89.44
1 68.29 97.19 82.74 59.64 95.05 77.34 79.35 99.07 89.21Page 7 of 10
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dataset NT15, we extracted 15 residues from N-terminus
of antibacterial peptides. After removing identical pep-
tides, we got 391 non-redundant peptides of length 15.
An equal number of random peptides have been extracted
from non-secretory proteins. Finally, dataset NT15 has
391 antibacterial peptides and 391 random peptides of
length 15. Similarly, we created datasets NT5 and NT10
after extracting 5 and 10 residues from N-terminus of anti-
bacterial peptides. In order to create dataset CT15, we
extracted 15 residues from the C-terminus of antibacterial
peptides. After removing identical peptides, we got 384
non-redundant antibacterial peptides and an equal
number of random peptides. Similarly, we created data-
sets CT5 and CT10. In order to create dataset NTCT15, we
extracted 15 residues from N-terminus and 15-residues
from C-terminus of antibacterial peptides. After removing
identical peptides, we got 431 non-redundant antibacte-
rial peptides; equal number of random peptides was
extracted from non-secretory proteins.
Blind or Independent dataset
All antibacterial peptides with residues between 15 and 80
were extracted from Swiss-Prot database and from this set
peptides present in our main dataset were removed.
Finally we got a dataset of 39 antibacterial peptides called
blind and independent dataset. All these 39 peptides are
experimentally verified and annotated as antibacterial
peptides according to Swiss-Prot.
Quantitative matrix
The quantitative matrix is basically a propensity of each
residue at a particular position. To classify the data of anti-
bacterial peptides and non-antibacterial peptides, differ-
ent quantitative matrices were generated for the N-
terminal and C-terminal residues. Following equation
was used to generate the quantitative matrices
Q (i,r) = P (i,r) - N (i,r) (1)
Where, Q(i,r) is the weight of residue r at position 'i' in the
matrix. 'r' can be any natural amino acid and the value of
'i' can vary from 1 to 15. P(i,r) and N(i,r) is the probability
of residue 'r' at position 'i' in antibacterial peptides and
non-antibacterial peptides respectively. Ei,r and Ai,r is
number residue 'r' at position 'i' in antibacterial peptides
and non-antibacterial peptides, respectively, and NPi,r is
P i,r( ) =
E
NP
i,r
i,r
(2)
N i,r( ) =
A
NN
i,r
i,r
(3)
Table 6: Overall performance of SVM, QM and ANN based models using 15 residues of N, C and N+C-termini. Last column shows 
performance of and consensus approaches where two or more than two models agree.
SVM QM ANN Consensus
Terminus Sen. Spec. Acc. Sen. Spec. Acc. Sen. Spec. Acc. Sen. Spec. Acc.
N 87.72 87.98 87.85 84.65 84.91 84.78 83.38 83.89 83.63 86.70 88.49 87.60
C 84.38 85.94 85.16 81.25 82.81 81.64 76.56 78.12 77.34 82.55 84.38 83.46
N+C 92.11 92.11 92.11 90.02 90.72 90.37 88.17 88.17 88.17 91.65 93.50 92.58
Table 5: The performance of ANN models using 15 residues of N, C and N+C termini of peptides.
N-terminal C-terminal N+C terminal
Threshold Sen. Spec. Acc. Sen. Spec. Acc. Sen. Spec. Acc.
0 100.00 0.00 50.00 100.00 0.00 50.00 100.00 0.00 50.00
0.1 95.40 53.96 74.68 92.97 48.18 70.57 94.20 72.85 83.53
0.2 92.58 63.43 78.01 89.06 59.11 74.09 92.58 79.12 85.85
0.3 89.51 70.84 80.18 85.94 64.84 75.39 91.42 82.83 87.12
0.4 86.96 75.96 81.46 83.33 69.27 76.30 89.33 85.38 87.35
0.5 85.17 79.28 82.23 80.21 74.74 77.47 88.17 88.17 88.17
0.6 83.38 83.89 83.63 76.56 78.12 77.34 87.94 90.02 88.98
0.7 78.01 86.70 82.35 71.35 82.03 76.69 86.54 92.58 89.56
0.8 71.87 91.30 81.59 64.06 86.98 75.52 83.53 93.97 88.75
0.9 58.82 93.86 76.34 54.43 91.15 72.79 76.80 96.06 86.43
1 0.00 100.00 50.00 0.00 100.00 50.00 1.16 100.00 50.58Page 8 of 10
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number of non-antibacterial peptides having residue 'r' at
position 'i'. The quantitative matrix generated by using
eq.(1), which is an addition matrix where the score of a
peptide is calculated by summing up the scores of each
residue at specific position along peptide sequence as
Where, L is the length of the peptide.
Support Vector Machine
In this study, all SVM models have been developed using
a freely available program SVM_LIGHT [33]. This pro-
gram allows users to run SVM using various kernels and
parameters. In this study, the accuracy was computed at a
cut-off score where sensitivity and specificity are nearly
equal.
Artificial Neural network
In order to develop ANN models we used Stuttgart Neural
Network Simulator, SNNS version 4.2 [34]. The advantage
of this package is that it allows incorporation of resulting
networks in ANSI C functions for use in stand-alone code.
The critical step in ANN is the optimization of the hidden
nodes and other learning parameters, in order to achieve
the best performance. Standard square error (SSE) was
used for the performance function. The number of epochs
has been taken where the value of SSE was minimum. For
N-terminal method we used the feed forward back propa-
gation type of ANN with single hidden layer having 17
nodes, 300 (20 × 15) input units and 1 output unit. The
training was carried out for 20000 epochs. Where as for C-
terminal approach we have used the feed forward back
propagation type of ANN with single hidden layer having
25 nodes, 300 (20 × 15) input units and 1 output unit.
Training was carried out for 10000 epochs. For N+C-ter-
minal approach feed forward back propagation ANN with
single layer having 25 nodes, 600 (20 × 30) input units
and a 1 output unit were used.
Evaluation of the Method
Five-fold cross-validation technique has been used to
evaluate the performance of all the models developed in
this study. In five fold cross-validation technique a dataset
is randomly divided into five sets, where each set consists
of nearly equal number of antibacterial peptides and non
antibacterial peptides. Four sets are used for training and
the remaining set for testing. This process is repeated five
times so that each set is used once for testing. The per-
formance of method is average performance of method
on five sets. Following parameters has been used for
assessing the performance of a method.
, where PPV is Probability of posi-
tive prediction.
Where TP and TN are correctly predicted antibacterial pep-
tides and non-antibacterial peptides respectively. FP and
FN are wrongly predicted antibacterial peptides and non
– antibacterial peptides respectively. The five fold cross
validation technique was used for evaluation of all the
three methods used.
Score Q i r
i
L
=
=
∑ ( , )
1
Sensitivity 100=
+
TP
TP FN
×
Specificity 100=
+
TN
TN FP
×
Accuracy =
+
+ + +
TP TN
TP FP TN FN
×100
PPV = ×
TP
TP FP+
100
Table 7: The performance of SVM, ANN and QM models using 15 residues of N+ C termini on independent dataset.
SVM QM ANN
Dataset Terminus CPP* PPV CPP PPV CPP PPV
39 original peptides of independent dataset N 23 58.97 21 53.84 19 48.71
C 30 76.92 29 74.35 27 69.23
N+C 26 66.66 27 69.23 25 64.10
39 randomly extracted peptides from main dataset N 35 89.74 33 84.61 34 87.17
C 38 97.43 35 89.74 31 79.48
N+C 36 92.30 34 87.17 36 92.30
24 peptides obtained from original independent dataset N 21 87.50 20 83.33 17 70.83
C 22 91.66 22 91.66 19 79.16
N+C 22 91.66 22 91.66 22 91.66
* CPP: Correctly predicted peptides.Page 9 of 10
(page number not for citation purposes)
BMC Bioinformatics 2007, 8:263 http://www.biomedcentral.com/1471-2105/8/263Availability and requirements
We developed a web server AntiBP available from http://
www.imtech.res.in/raghava/antibp/ for predicting bacte-
rial peptides using models developed in this study. This
web server was developed on SUN server (model T-1000)
under Solaris environment using programming language
PERL. It also allows mapping and searching of antibacte-
rial in a protein sequence. This server is free for academic
use, commercials should contact author for licence.
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